Related references
Note: Only part of the references are listed.Site-specific DOTA/europium-labeling of recombinant human relaxin-3 for receptor-ligand interaction studies
Wei-Jie Zhang et al.
AMINO ACIDS (2012)
Structure and Function Relationship of Murine Insulin-like Peptide 5 (INSL5): Free C-Terminus Is Essential for RXFP4 Receptor Binding and Activation
Alessia Begi et al.
BIOCHEMISTRY (2011)
H3 Relaxin Demonstrates Antifibrotic Properties via the RXFP1 Receptor
Mohammed Akhter Hossain et al.
BIOCHEMISTRY (2011)
The Roles of the A- and B-Chains of Human Relaxin-2 and -3 on Their Biological Activity
Mohammed Akhter Hossain et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2011)
The Relaxin Peptide Family – Structure, Function and Clinical Applications
Linda Jiaying Chan et al.
PROTEIN AND PEPTIDE LETTERS (2011)
Effect of helix-promoting strategies on the biological activity of novel analogues of the B-chain of INSL3
Fazel Shabanpoor et al.
AMINO ACIDS (2010)
The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist
Mohammed Akhter Hossain et al.
AMINO ACIDS (2010)
Design and recombinant expression of insulin-like peptide 5 precursors and the preparation of mature human INSL5
Xiao Luo et al.
AMINO ACIDS (2010)
Membrane receptors: Structure and function of the relaxin family peptide receptors
Roy C. K. Kong et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
New Roles for INSL3 in Adults Regulation of Bone Metabolism and Association of RXFP2 Gene Mutations with Osteoporosis
Alberto Ferlin et al.
RELAXIN AND RELATED PEPTIDES: FIFTH INTERNATIONAL CONFERENCE (2009)
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study
John R. Teerlink et al.
LANCET (2009)
Synthesis, conformation, and activity of human insulin-like peptide 5 (INSL5)
Mohammed Akhter Hossain et al.
CHEMBIOCHEM (2008)
Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135)
Jessica Zhu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Relaxin promotes prostate cancer progression
Shu Feng et al.
CLINICAL CANCER RESEARCH (2007)
Analog of H2 relaxin exhibits antagonistic properties and impairs prostate tumor growth
Josh D. Silvertown et al.
FASEB JOURNAL (2007)
Insulin-like peptide 6: Characterization of secretory status and posttranslational modifications
Chunxia Lu et al.
ENDOCRINOLOGY (2006)
'Relaxin' the stiffened heart and arteries: The therapeutic potential for relaxin in the treatment of cardiovascular disease
Chrishan S. Samuel et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Relaxin - a pleiotropic hormone and its emerging role for experimental and clinical therapeutics
Thomas Dschietzig et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Relaxin enhances the oncogenic potential of human thyroid carcinoma cells
Sabine Hombach-Klonisch et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7
RL Vinall et al.
ONCOGENE (2006)
International union of pharmacology LVII: Recommendations for the nomenclature of receptors for relaxin family peptides
RA Bathgate et al.
PHARMACOLOGICAL REVIEWS (2006)
Relaxin-3:: Improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo
RAD Bathgate et al.
BIOCHEMISTRY (2006)
Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF
WC Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The role of relaxin in endometrial cancer
AA Kamat et al.
CANCER BIOLOGY & THERAPY (2006)
H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis
JD Silvertown et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
New insights into biological roles of relaxin and relaxin-related peptides
JI Park et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2005)
Relaxin: Antifibrotic Properties and Effects in Models of Disease
Chrishan S. Samuel
CLINICAL MEDICINE & RESEARCH (2005)
Central relaxin-3 administration causes hyperphagia in male Wistar rats
BMC McGowan et al.
ENDOCRINOLOGY (2005)
Synthetic human insulin 4 does not activate the G-protein-coupled receptors LGR7 or LGR8
F Lin et al.
JOURNAL OF PEPTIDE SCIENCE (2004)
Relaxin's physiological roles and other diverse actions
OD Sherwood
ENDOCRINE REVIEWS (2004)
Elevated concentrations of serum relaxin are associated with metastatic disease in breast cancer patients
C Binder et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo
CS Samuel et al.
ENDOCRINOLOGY (2004)
Emerging role of relaxin in renal and cardiovascular function
KP Conrad et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Paracrine regulation of mammalian oocyte maturation and male germ cell survival
K Kawamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135
CL Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase
LC Jadeski et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Adenovirus-mediated expression of human prorelaxin promotes the invasive potential of canine mammary cancer cells
JD Silvertown et al.
ENDOCRINOLOGY (2003)
INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent
J Kumagai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activation of orphan receptors by the hormone relaxin
SY Hsu et al.
SCIENCE (2002)
The primary structure and the disulfide links of the bovine relaxin-like factor (RLF)
EE Büllesbach et al.
BIOCHEMISTRY (2002)
Synthesis and conformational analysis of the insulin-like 4 gene product
EE Bullesbach et al.
JOURNAL OF PEPTIDE RESEARCH (2001)
The relaxin receptor-binding site geometry suggests a novel gripping mode of interaction
EE Büllesbach et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
